A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates

Thyroid

Volumn 19, Issue 8, 2009, Pages 837-842

  Marchetti, Ivo ^a   Lessi, Francesca ^a   Mazzanti, Chiara Maria ^a   Bertacca, Gloria ^a   Elisei, Rossella ^b   Coscio, Giancarlo Di ^a   Pinchera, Aldo ^b   Bevilacqua, Generoso ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; VALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SMEAR; THYROID PAPILLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY, FOLLICULAR; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS B-RAF; THYROID GLAND; THYROID NEOPLASMS;

EID: 68349104793     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0074     Document Type: Article

References (41)

1. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559.
2. Udelsman R, Chen H 1999 The current management of thyroid cancer. Adv Surg 33:1-27.
3. Miccoli P, Minuto MN, Galleri D, D'Agostino J, Basolo F, Antonangeli L, Aghini-Lombardi F, Berti P 2006 Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J Surg 76: 123-126. (Pubitemid 43363011)
4. Mazzaferri EL 2006 Managing small thyroid cancers. JAMA 295:2179-2182.
5. Brander A, Viikinkoski P, Nickels J, Kivisaari L 1991 Thyroid gland: US screening in a random adult population. Radiology 181:683-687.
6. Tan GH, Gharib H 1997 Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226-231. (Pubitemid 27061578)
7. Clark KJ, Cronan JJ, Scola FH 1995 Color Doppler sonography: anatomic and physiologic assessment of the thyroid. J Clin Ultrasound 23:215-223.
8. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedus L 2002 Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 87:112-117.
9. Ravetto C, Colombo L, Dottorini ME 2000 Usefulness of fineneedle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 90:357-436 (Pubitemid 32011847)
10. Werga P, Wallin G, Skoog L, Hamberger B 2000 Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg 24:907-912. (Pubitemid 30461211)
11. Gharib H, Goellner JR, Johnson DA 1993 Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med 13:699-709.
12. Hamberger B, Gharib H, Melton LJ, Goellner JR, Zinsmeister AR 1982 Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 73: 381-384. (Pubitemid 12031790)
13. Gharib H, Goellner JR 1993 Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289. (Pubitemid 23046388)
14. Chow LS, Gharib H, Goellner JR, van Heerden JA 2001 Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid 11:1147-1151. (Pubitemid 34041895)
15. Harris PE 2002 The management of thyroid cancer in adults: a review of new guidelines. Clin Med 2:144-146.
16. Miller B, Burkey S, Lindberg G, Snyder WH, Nwariaku FE 2004 Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188:459-462. (Pubitemid 39491085)
17. Haymart MR, Greenblatt DY, Elson DF, Chen H 2008 The role of intraoperative frozen section if suspicious for papillary thyroid cancer. Thyroid 18:419-423.
18. Xing M 2005 BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245-262
19. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627. (Pubitemid 36553510)
20. Fukushima T, Suzuki S, Mashiko M, Ohtake T, Endo Y, Takebayashi Y, Sekikawa K, Hagiwara K, Takenoshita S 2003 BRAF mutations in papillary carcinomas of the thyroid. Oncogene 22:6455-6457. (Pubitemid 37281692)
21. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404. (Pubitemid 37452745)
22. Chiloeches A, Marais R 2006 Is BRAF the achilles' heel of thyroid cancer? Clin Cancer Res 12:1661-1664.
23. Trovisco V, Soares P, Sobrinho-Simoes M 2006 B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 37:781-786. (Pubitemid 43902956)
24. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW 2005 BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90:6373-6379. (Pubitemid 41759286)
25. Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW 2004 Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89:2867-2872. (Pubitemid 38766378)
26. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 28:742-762. (Pubitemid 350294294)
27. Rowe LR, Bentz BG, Bentz JS 2006 Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules. Cytojournal 10:3-10.
28. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA 2002 Mutations of the BRAF gene in human cancer. Nature 417:949-954. (Pubitemid 34716871)
29. Haugen BR, Woodmansee WW, McDermott MT 2002 Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol (Oxf) 56:281-290.
30. Boyd LA, Earnhardt RC, Dunn JT, Frierson HF, Hanks JB 1998 Preoperative evaluation and predictive value of fineneedle aspiration and frozen section of thyroid nodules. J Am Coll Surg 187:494-502.
31. Cvejeic DS, Savin SB, Petrovic IM, Paunovic IR, Tatic SB, Havelka MJ 2005 Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size. Head Neck 27:1049-1055.
32. Matthews P, Jones CJ, Skinner J, Haughton M, de Micco C, Wynford-Thomas D 2001 Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications. J Pathol 194:183-193. (Pubitemid 32519968)
33. Miettinen M, Karkkainen P 1996 Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumors. Virchows Arch 429:213-219.
34. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV 2006 BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 15:136-143. (Pubitemid 44325474)
35. Domingues R, Mendonca E, Sobrinho L, Bugalho MJ 2005 Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma. Cytopathology 16:27-31. (Pubitemid 40293059)
36. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L, Basolo F, Santoro M 2004 Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89:5175-5180. (Pubitemid 39391466)
37. Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH 2004 Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 10:2761-2765. (Pubitemid 38509152)
38. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P, Basolo F 2007 Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92:4085-4090.
39. Gupta-Abramson V, Troxel AB, Nellore A, Puttaswamy K, Redlinger M, Ransone K, Mandel SJ, Flaerthy KT, Loevner LA, O'Dwyer PJ, Brose MS 2008 Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol 26:4714-4719.
40. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803. (Pubitemid 43997716)
41. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142.